Abstract:Background: Bone morphogenetic protein 2 (BMP2), as a growth factor, has the strongest effect on bone formation in all growth factors that have been known. It is considered as a bone-inducing substance with most desirable prospects. Objective: To construct a human BMP2 gene eukaryotic expression vector, and observe its expression in vitro. Design, Time and Setting: Self-control experiment was performed at Central Laboratory of Molecular Biology, Tongji Medical College of Huangzhong University of Science and Technology from July 2005 to May 2006. Materials: PcDNA3.1(+) plasmid was a gift from Doctor Zuo Shi of Tongji Medical College of Huazhong University of Science and Technology. Human osteosarcoma tissues were provided by Department of Orthopedics, Wuhan Union Hospital, Tongji Medical College of Huangzhong University of Science and Technology. Methods: The total RNA was extracted from human osteosarcoma. cells. The human BMP2 cDNA was amplified by RT-PCR and inserted into pGEM-T vector to construct BMP2 vector. After BMP2 vector had been transformed into E. coli DH-5α, the poşitive clones were screened out. Then the recombinant plasmids were identified by restriction enzyme digestion and DNA sequencing. By digestion of pGEM-T-hBMP-2 plasmid with RcoR I and pcDNA3.1 eukaryotic expression vector with Not I, the BMP2 cDNA in the pGEM-T cloning vector was inserted into the pcDNA3.1 eukaryotic expression vector. The recombinant plasmids were identified by restriction fragments electrophoresis, PCR and DNA sequencing. Mouse bone marrow stromal cells (BMSCs) were transfected with the vectors using lipofecarmin reagents. The expression of BMP-2 was detected by RT-PCR and immunohistochemical analysis. Main Outcome Measure: 1Results of the total RNA extracted from human osteosarcoma cells amplified by RT-PCR; 2 The construction and identification by restriction fragments electrophoresis of pGEM-T-hBMP-2 and pcDNA3.1-hBMP-2; 3 Expression of BMP-2 in mouse BMSCs. Results: The total RNA extracted from human osteosarcoma. cells obtained the 1.2 kbp fragments of BMP2 amplified by RT-PCR. Restriction fragments electrophoresis, PCR and DNA sequencing identified that the clone of BMP2 gene were successful and the construction of recombinant pcDNA3.1-hBMP-2 plasmids was right. The recombinant plasmids could express human BMP2 in mouse MSCs cultured in vitro. Conclusion: The findings suggest that it is successful to clone human BMP2 and construct its eukaryotic expression vector.

Expression and Localization of Polo-like Kinase 2 in Osteosarcoma Cells

Expression of BMP-2 in Osteosarcoma of the Jaw Bone and Its Clinical Significance

The Expression of BMP-2mRNA in Osteosarcoma of the Jaw and Its Relationship to Lymph Node Metastasis

Measurement of the Mrna Level of Polo-like Kinase 1 in Bronchoscopic Bioptic Specimens by Real-Time Quantitative PCR

Eukaryotic Expression of Casein Kinase 1 and its Localization in Tumor Cells

Construction of Human Serine/threonine Kinase 1 Overexpressed Cell Line and Function Detection of Serine/threonine Kinase 1

Chondroitin Polymerizing Factor (CHPF) Promotes Cell Proliferation and Tumor Growth in Human Osteosarcoma by Inhibiting SKP2's Ubiquitination While Activating the AKT Pathway

Construction of Eukaryotic Expression Vector Containing B7-1/GFP Gene and Its Expression in Osteosarcoma Cell Line

Expression and Identification of Mutated Osteoprotegerin in Culture Cells and Larvae of Silkworm

Targeted PLK1 suppression through RNA interference mediated by high‐fidelity Cas13d mitigates osteosarcoma progression via TGF‐β/Smad3 signalling

Construction of the recombinant adenovirus mediated short hairpin RNA to silence Polo-like kinase 1 and its biomedical application

[Effect of EPHA2-siRNA Plasmid on Biological Behavior of Human Osteosarcoma Cells in Vitro].

Polo-like kinase 1 as a potential therapeutic target for osteosarcoma.

[Knockdown of Cyclin A2 Expression by Small Interfering RNA in MG-63 Cells].

Effect of PLK1 inhibitor on proliferation of osteosarcoma cells and its mechanism

Biodegradable Carbon Dioxide‐Derived Non‐Viral Gene Vectors for Osteosarcoma Gene Therapy

POLO-LIKE KINASE1 GENE EXPRESSION AND ITS CLINICOPATHOLOGICAL SIGNIFICANCE IN GASTRIC CARCINOMA

Construction of shRNA expression plasmids targeting the Pyk2 gene and their expression in Lovo cells

Construction and expression in vitro of bone morphogenetic protein 2 eukaryotic experssion vector

High Expression of PKMYT1 Predicts Poor Prognosis and Aggravates the Progression of Osteosarcoma Via the NF-κB Pathway in MG63 Cells.

G protein-coupled receptor 54 gene expression in osteosarcoma and its clinical significance